Chenjun Huang
Nanjing, 210029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Single-cell analysis identifies a stemness-associated tumor cell subpopulation and develops a prognostic scoring model in esophageal squamous cell carcinoma.
Journal: Translational oncology
Published: October 24, 2025
Cholesterol metabolism shapes immune low-response states in LUAD: a multi-omics cholesterol metabolism signature predicts immunotherapy benefit and identifies DHCR7 as a therapeutic target.
Journal: Frontiers in immunology
Published: August 31, 2025
Metabolic reprogramming signature predicts immunotherapy efficacy in lung adenocarcinoma: Targeting SLC25A1 to overcome immune resistance.
Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
Published: August 30, 2025
Integrative Single-Cell and Machine Learning Analysis Reveals Immune Microenvironment Remodelling in Lymph Node Metastasis of Lung Adenocarcinoma.
Journal: Journal of cellular and molecular medicine
Published: July 12, 2025
The Critical Role of APOE+ Macrophages in the Immune Microenvironment and Prognosis of Lung Adenocarcinoma.
Journal: Journal of cellular and molecular medicine
Published: May 30, 2025
Single-cell and multi-omics analysis reveals the role of stem cells in prognosis and immunotherapy of lung adenocarcinoma patients.
Journal: Frontiers in immunology
Published: May 25, 2025
Editorial: Molecular mechanisms and therapeutic strategies in inflammation.
Journal: Frontiers in immunology
Published: May 11, 2025
The integrated single-cell analysis developed an immunogenic cell death signature to predict lung adenocarcinoma prognosis and immunotherapy.
Journal: Aging
Published: May 30, 2023
An ultrasensitive method for detecting mutations from short and rare cell-free DNA.
Journal: Biosensors & bioelectronics
Published: May 23, 2023
Immune checkpoint inhibitors in neoadjuvant therapy of non-small cell lung cancer: a systematic review and meta-analysis.
Journal: Journal of thoracic disease
Published: October 18, 2021
Concurrent use of anlotinib overcomes acquired resistance to EGFR-TKI in patients with advanced EGFR-mutant non-small cell lung cancer.
Journal: Thoracic cancer
Published: June 28, 2021
Prognostic value of miR-1181 in non-small cell lung cancer and its regulatory effect on tumor progression.
Journal: Experimental and therapeutic medicine
Published: September 28, 2020
Last Updated: 09/26/2026